GRID2 (extracellular) Blocking Peptide (#BLP-GC039) is the original antigen used for immunization during Anti-GRID2 (extracellular) Antibody (#AGC-039) generation. The blocking peptide binds and ‘blocks’ Anti-GRID2 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of rat brain membranes (lanes 1 and 4), mouse brain membranes (lanes 2 and 5) and human U87-MG glioblastoma cell lysate (lines 3 and 6):
- Mouse brain sections (1:200).
Pernice, H.F. et al. (2019) Int. J. Mol. Sci. 20, 1797.
- (C)KMITTLFDTMRIE, corresponding to amino acid residues 206-218 of rat GluD2 (Accession Q63226).